3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Triple Negative Breast Neoplasms
5
Neoplasms
5
Breast Neoplasms
5
Recurrence
2
Ovarian Neoplasms
2
Hypersensitivity
2
Squamous Cell Lung Cancer
1
Solid Tumors
1
Neoplasm Metastasis
1
Glioblastoma
1
Fanconi Anemia, Complementation Group D1
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Female
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Advance Solid Tumors
1
Interventions
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
iniparib
1
Tamoxifen
1
Paclitaxel
1
Mastectomy, Segmental
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Breast Cancer Female
×
iniparib
×
Clear all
NCT01204125
2017-03-22
SOLTI NEOPARP
Sanofi
Phase 2
Completed
141 enrolled